[Proneuron1] Press Release: Mount Sinai and Kessler Institute Now Enrolling for Proneuron's Phase II Study of ProCord

[marjie hadad]

For Release

 

The Mount Sinai Medical Center and Kessler Institute for Rehabilitation

 Are Now Enrolling for Proneuron’s Phase II Study of 

ProCord for Neurologically Complete Spinal Cord Injury 

Announcement Made at the Rally for the Cure in NYC

 

New York, NY, June 6, 2004 ---- The Mount Sinai Medical Center (NYC) and
Kessler Institute for Rehabilitation (West Orange, NJ) are now enrolling
for Proneuron’s Phase II trial of ProCord, for complete spinal cord
injury.  The official announcement was made at the Rally For the Cure,
at the Winter Garden Financial Center in New York City.

 

“This collaborative effort between leading centers of care for persons
who have sustained a spinal cord injury is a testimony to the importance
of how 'working together we can make things happen'. This is the message
for all professionals involved in the care of spinal cord injury,” said
Dr. Steven Kirshblum, Principal Investigator and Director of Spinal Cord
Injury Service, Kessler Institute for Rehabilitation. 

 

Patients found eligible for the study will be randomly assigned to
either a treatment or control group. Patients in the control group will
not receive the study treatment.  All control and treatment patients
will receive standard spinal cord injury care and rehabilitation and
will receive follow-up testing for one year.  

 

“We selected this venue to jointly announce the launch of this trial at
our centers to draw attention to the importance of collaboration if we
are to be successful. We need everyone to spread the word to doctors,
family and friends so that we can reach people in the crucial first few
days after their injury,” said Dr. Kristjan Ragnarsson, the Principal
Investigator and head of the Department of Rehabilitation Medicine at
Mount Sinai. 

 

This international, multi-center, randomized-controlled, experimental
study is open to patients who meet eligibility criteria, including but
not limited to an ASIA Grade A injury between C5-T11 vertebrae, within
14 days of injury.  Asia Grade A is defined as patients who have no
feeling or movement below the point of injury.  

 

Patient, Immediate Family of Patient and/or Physician inquiries:

24 hour a day Patient Recruitment Center: 

Email: clinical.trial at proneuron.com 
Telephone: 1 866 539 0767 (U.S. toll free) or 1 506 652 3486. 
Fax: 1 866-214-7078 

*Callers outside of the U.S., please use standard international dialing
code

For additional information:  <http://www.proneuron.com/>
www.proneuron.com

 

  

In addition to Kessler Institute for Rehabilitation and The Mount Sinai
Medical Center, patients can be enrolled in the trial at Craig Hospital
in Denver, Colorado, Principal Investigator, Dr. Daniel P. Lammertse and
Sheba Medical Center in Israel, Principal Investigator, Dr. Nachshon
Knoller. Shepherd Center in Atlanta, GA, Principal Investigator, Dr.
David Apple, is also anticipated to begin enrollment in 2004 and is
already taking an active role in the study.


 


About The Mount Sinai Medical Center


The Mount Sinai Medical Center includes The Mount Sinai Hospital, one of
the country’s finest teaching hospitals, and Mount Sinai School of
Medicine, internationally recognized for ground-breaking research, and
innovative approaches to medical education. The Mount Sinai Department
of Rehabilitation Medicine is a center of excellence in the delivery of
complete care for people with disabilities and is consistently ranked
among the best in the nation in surveys, such as US News & World
Report’s best hospital issue. It is designated by the National Institute
on Disability and Rehabilitation Research, U.S. Department of Education
as one of the nation’s 16 Spinal Cord Injury Model Systems of Care. A
wide range of comprehensive medical and rehabilitation services is
available for individuals with spinal cord injuries, brain injuries, and
a variety of other neuromuscular, musculosketetal, and chronic
conditions.

 


About Kessler Institute for Rehabilitation


For over 55 years, Kessler has pioneered the course of physical medicine
and rehabilitation.  Today, Kessler Institute for Rehabilitation, a
Select Medical company, continues to lead this field through its
comprehensive, medically-based rehabilitation  programs in spinal cord
injury, brain injury, stroke, amputation and orthopedic, neuromuscular
and musculoskeletal disorders.  In fact, Kessler is one of only 16
centers1 in the country to be designated as a model system for the
treatment and research of spinal cord injury. With four hospital centers
located in West Orange, East Orange, Saddle Brook and Chester, NJ,
Kessler is internationally recognized for its innovative treatment,
quality of care, research and education programs.  Kessler is also
consistently listed among the nation’s best rehabilitation hospitals and
the top such centers in the east by U.S. News & World Report.    

 

1 Kessler, the University of Medicine and Dentistry of New Jersey-NJ
Medical School and Kessler Medical Rehabilitation Research and Education
Corporation, comprise the Northern New Jersey Spinal Cord Injury System.

 

Press inquiries: 

Marjie Hadad, (Media Liaison) Proneuron, +972-55-365-220 or
<mailto:Marjie.hadad at proneuron.com> Marjie.hadad at proneuron.com

Debra Kaplan,  (Associate Director of External Relations) Mount Sinai
School of Medicine, 212-659-9045 or debra.kaplan at mssm.edu

Gail Solomon, (Director of Corporate Communications) Kessler Institute
for Rehabilitation, 973-243-6879; pager 973-705-6813, or
gsolomon at kessler-rehab.com

 

-------------- next part --------------
An HTML attachment was scrubbed...
URL: http://mailman.intermedia.net/pipermail/proneuron1/attachments/20040610/f405b9bc/attachment-0001.htm